173 related articles for article (PubMed ID: 23436052)
1. MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma.
Sedlacik J; Winchell A; Kocak M; Loeffler RB; Broniscer A; Hillenbrand CM
AJNR Am J Neuroradiol; 2013 Jul; 34(7):1450-5. PubMed ID: 23436052
[TBL] [Abstract][Full Text] [Related]
2. Treatment-Related Noncontiguous Radiologic Changes in Children With Diffuse Intrinsic Pontine Glioma Treated With Expanded Irradiation Fields and Antiangiogenic Therapy.
Patay Z; Merchant TE; Nguyen R; Pierson CR; Onar-Thomas A; Broniscer A
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1295-1305. PubMed ID: 29165288
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.
Broniscer A; Baker JN; Tagen M; Onar-Thomas A; Gilbertson RJ; Davidoff AM; Pai Panandiker AS; Leung W; Chin TK; Stewart CF; Kocak M; Rowland C; Merchant TE; Kaste SC; Gajjar A
J Clin Oncol; 2010 Nov; 28(31):4762-8. PubMed ID: 20921456
[TBL] [Abstract][Full Text] [Related]
4. Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
Vajapeyam S; Brown D; Billups C; Patay Z; Vezina G; Shiroishi MS; Law M; Baxter P; Onar-Thomas A; Fangusaro JR; Dunkel IJ; Poussaint TY
AJNR Am J Neuroradiol; 2020 Apr; 41(4):718-724. PubMed ID: 32241771
[TBL] [Abstract][Full Text] [Related]
5. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).
Poussaint TY; Kocak M; Vajapeyam S; Packer RI; Robertson RL; Geyer R; Haas-Kogan D; Pollack IF; Vezina G; Zimmerman R; Cha S; Patay Z; Boyett JM; Kun LE
Neuro Oncol; 2011 Apr; 13(4):417-27. PubMed ID: 21297126
[TBL] [Abstract][Full Text] [Related]
6. Measurable Supratentorial White Matter Volume Changes in Patients with Diffuse Intrinsic Pontine Glioma Treated with an Anti-Vascular Endothelial Growth Factor Agent, Steroids, and Radiation.
Svolos P; Reddick WE; Edwards A; Sykes A; Li Y; Glass JO; Patay Z
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1235-1241. PubMed ID: 28428205
[TBL] [Abstract][Full Text] [Related]
7. Multimodal Magnetic Resonance Imaging of Treatment-Induced Changes to Diffuse Infiltrating Pontine Gliomas in Children and Correlation to Patient Progression-Free Survival.
Calmon R; Puget S; Varlet P; Beccaria K; Blauwblomme T; Grevent D; Sainte-Rose C; Castel D; Dufour C; Dhermain F; Bolle S; Saitovitch A; Zilbovicius M; Brunelle F; Grill J; Boddaert N
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):476-485. PubMed ID: 28871999
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of
Tinkle CL; Duncan EC; Doubrovin M; Han Y; Li Y; Kim H; Broniscer A; Snyder SE; Merchant TE; Shulkin BL
J Nucl Med; 2019 Mar; 60(3):312-319. PubMed ID: 30072503
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial.
Zaghloul MS; Eldebawy E; Ahmed S; Mousa AG; Amin A; Refaat A; Zaky I; Elkhateeb N; Sabry M
Radiother Oncol; 2014 Apr; 111(1):35-40. PubMed ID: 24560760
[TBL] [Abstract][Full Text] [Related]
10. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
[TBL] [Abstract][Full Text] [Related]
11. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.
Kilburn LB; Kocak M; Baxter P; Poussaint TY; Paulino AC; McIntyre C; Lemenuel-Diot A; Lopez-Diaz C; Kun L; Chintagumpala M; Su JM; Broniscer A; Baker JN; Hwang EI; Fouladi M; Boyett JM; Blaney SM
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29090526
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Vandetanib plus Everolimus for the Treatment of
Carvalho DM; Richardson PJ; Olaciregui N; Stankunaite R; Lavarino C; Molinari V; Corley EA; Smith DP; Ruddle R; Donovan A; Pal A; Raynaud FI; Temelso S; Mackay A; Overington JP; Phelan A; Sheppard D; Mackinnon A; Zebian B; Al-Sarraj S; Merve A; Pryce J; Grill J; Hubank M; Cruz O; Morales La Madrid A; Mueller S; Carcaboso AM; Carceller F; Jones C
Cancer Discov; 2022 Feb; 12(2):416-431. PubMed ID: 34551970
[TBL] [Abstract][Full Text] [Related]
14. Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.
Poussaint TY; Vajapeyam S; Ricci KI; Panigrahy A; Kocak M; Kun LE; Boyett JM; Pollack IF; Fouladi M
Neuro Oncol; 2016 May; 18(5):725-34. PubMed ID: 26487690
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise?
Rizzo D; Scalzone M; Ruggiero A; Maurizi P; Attinà G; Mastrangelo S; Lazzareschi I; Ridola V; Colosimo C; Caldarelli M; Balducci M; Riccardi R
J Chemother; 2015 Feb; 27(2):106-10. PubMed ID: 25466729
[TBL] [Abstract][Full Text] [Related]
16. Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma.
Tinkle CL; Simone B; Chiang J; Li X; Campbell K; Han Y; Li Y; Hover LD; Molitoris JK; Becksfort J; Lucas JT; Patay Z; Baker SJ; Broniscer A; Merchant TE
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):838-847. PubMed ID: 31785339
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
[TBL] [Abstract][Full Text] [Related]
18. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria.
Jansen MH; Veldhuijzen van Zanten SE; Sanchez Aliaga E; Heymans MW; Warmuth-Metz M; Hargrave D; van der Hoeven EJ; Gidding CE; de Bont ES; Eshghi OS; Reddingius R; Peeters CM; Schouten-van Meeteren AY; Gooskens RH; Granzen B; Paardekooper GM; Janssens GO; Noske DP; Barkhof F; Kramm CM; Vandertop WP; Kaspers GJ; van Vuurden DG
Neuro Oncol; 2015 Jan; 17(1):160-6. PubMed ID: 24903904
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging is the preferred method to assess treatment-related skeletal changes in children with brain tumors.
Kaste SC; Kaufman RA; Gajjar A; Broniscer A
Pediatr Blood Cancer; 2013 Sep; 60(9):1552-6. PubMed ID: 23526749
[TBL] [Abstract][Full Text] [Related]
20. T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.
Harward S; Harrison Farber S; Malinzak M; Becher O; Thompson EM
Childs Nerv Syst; 2018 Mar; 34(3):449-455. PubMed ID: 29151166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
